Originally posted here:
Sandoz submits Biologics License Application for proposed biosimilar trastuzumab to US FDA
ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital
Read more from the original source:
ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital
Denali Therapeutics to Present New Data on ETV:IDS (DNL310) for the Potential Treatment of Hunter Syndrome at WORLDSymposium™
T2 Biosystems Reminds Stockholders to Vote at the Upcoming Annual Meeting
See original here:
T2 Biosystems Reminds Stockholders to Vote at the Upcoming Annual Meeting
Codexis to Participate in Upcoming Virtual Healthcare Conferences
Read the rest here:
Codexis to Participate in Upcoming Virtual Healthcare Conferences
Valneva – Déclaration d’actions et de droits de vote – Janvier 2021
Trading in Novo Nordisk shares by board members, executives and associated persons on 3-4 February 2021
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies
Read more from the original source:
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies
Franciosi Consulting Assessing New Potential Treatments for Asthma and COPD
Arecor Limited: First Patient Dosed in Phase I Clinical Trial of Ultra-Concentrated Rapid Acting Insulin Candidate, AT278, for Diabetes
Polydex Pharmaceuticals Issues Third Quarter Financial Results
BioRestorative Therapies Emerges from Chapter 11 Reorganization
Read more here:
BioRestorative Therapies Emerges from Chapter 11 Reorganization
vTv Therapeutics Announces Topline Results of Phase 2 Elevage Study of Azeliragon in Patients with Mild Alzheimer’s Disease and Type 2 Diabetes
Tauriga Sciences Inc. Updates Shareholders on Progress Pursuant to the Collaboration Agreement with Aegea Biotechnologies Inc. for New COVID-19…
Auris Medical Launches Website for AM-301-focused Subsidiary, Altamira Medica
Ovid Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Neuronetics to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
LIDDS Interim report January – September 2020
Follow this link:
LIDDS Interim report January – September 2020
Novan to Present at the Virtual Investor KOL Roundtable
Go here to see the original:
Novan to Present at the Virtual Investor KOL Roundtable